BridgeBio Pharma, Inc. (BBIO)
USD 29.02
(-7.49%)
USD 29.02
(-7.49%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -565.46 Million USD | -62.48% |
| 2022 | -397.44 Million USD | 34.46% |
| 2021 | -533.83 Million USD | -15.11% |
| 2020 | -465.74 Million USD | -67.8% |
| 2019 | -279.82 Million USD | -52.7% |
| 2018 | -183.41 Million USD | -317.57% |
| 2017 | -43.55 Million USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 5.33 Million USD | 92.53% |
| 2024 Q2 | -171.07 Million USD | -360.05% |
| 2023 Q3 | -157.69 Million USD | -16.86% |
| 2023 Q1 | -117.6 Million USD | -4.18% |
| 2023 FY | - USD | -62.48% |
| 2023 Q2 | -134.94 Million USD | -14.74% |
| 2023 Q4 | -169.22 Million USD | -7.32% |
| 2022 Q3 | -113.7 Million USD | -510.52% |
| 2022 Q2 | 27.69 Million USD | 117.71% |
| 2022 Q1 | -156.44 Million USD | -14.07% |
| 2022 FY | - USD | 34.46% |
| 2022 Q4 | -112.88 Million USD | 0.72% |
| 2021 FY | - USD | -15.11% |
| 2021 Q3 | -149.68 Million USD | -64.06% |
| 2021 Q1 | -159.97 Million USD | -28.95% |
| 2021 Q2 | -91.23 Million USD | 42.97% |
| 2021 Q4 | -137.14 Million USD | 8.37% |
| 2020 Q4 | -124.06 Million USD | -4.05% |
| 2020 Q2 | -125.46 Million USD | -25.37% |
| 2020 Q1 | -100.07 Million USD | -23.38% |
| 2020 FY | - USD | -67.8% |
| 2020 Q3 | -119.23 Million USD | 4.96% |
| 2019 Q1 | -66.13 Million USD | -2.89% |
| 2019 FY | - USD | -52.7% |
| 2019 Q4 | -81.11 Million USD | -38.86% |
| 2019 Q3 | -58.41 Million USD | 19.34% |
| 2019 Q2 | -72.41 Million USD | -9.49% |
| 2018 Q3 | -40.84 Million USD | -15.2% |
| 2018 Q4 | -64.28 Million USD | -57.38% |
| 2018 Q1 | -42.39 Million USD | 0.0% |
| 2018 FY | - USD | -317.57% |
| 2018 Q2 | -35.45 Million USD | 16.37% |
| 2017 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| AbCellera Biologics Inc. | -192.15 Million USD | -194.272% |
| Alkermes plc | 495.04 Million USD | 214.225% |
| Agenus Inc. | -145.92 Million USD | -287.509% |
| Aptorum Group Limited | -9.59 Million USD | -5790.907% |
| Ardelyx, Inc. | -55.35 Million USD | -921.549% |
| Dyadic International, Inc. | -8.22 Million USD | -6771.032% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -194218.9% |
| Lantern Pharma Inc. | -15.78 Million USD | -3481.929% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -2739.779% |
| Novavax, Inc. | -487.39 Million USD | -16.02% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -696.165% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -620.406% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -3046.129% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -5572.833% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -885.549% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | -48.82% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -2245.182% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 106993.762% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -259.724% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -655.823% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -2705.04% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -2282.423% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -2352.372% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -363.107% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -118.968% |
| AlloVir, Inc. | -190.14 Million USD | -197.386% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -221.889% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1832.695% |
| Bicycle Therapeutics plc | -183.4 Million USD | -208.325% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -241.836% |
| ChromaDex Corporation | -3.89 Million USD | -14421.52% |
| Chimerix, Inc. | -92.97 Million USD | -508.2% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -1172.525% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -402.486% |
| CRISPR Therapeutics AG | -202.7 Million USD | -178.967% |
| Precision BioSciences, Inc. | -32.04 Million USD | -1664.771% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -228.323% |
| Fortress Biotech, Inc. | -133.64 Million USD | -323.118% |
| Fortress Biotech, Inc. | -133.64 Million USD | -323.118% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -631.117% |
| ImmuCell Corporation | -2.5 Million USD | -22481.893% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -333.571% |
| Immix Biopharma, Inc. | -16.13 Million USD | -3404.465% |
| Incyte Corporation | 919.42 Million USD | 161.502% |
| Innoviva, Inc. | 248.96 Million USD | 327.132% |
| IO Biotech, Inc. | -91.22 Million USD | -519.84% |
| Jaguar Health, Inc. | -33.13 Million USD | -1606.764% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -271.586% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 655.868% |
| ContextLogic Inc. | -324 Million USD | -74.527% |
| MiMedx Group, Inc. | 40.51 Million USD | 1495.631% |
| MEI Pharma, Inc. | 26.38 Million USD | 2243.548% |
| NextCure, Inc. | -59.03 Million USD | -857.787% |
| Onconetix, Inc. | -36.7 Million USD | -1440.502% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 25400.582% |
| Opthea Limited | -200.01 Million USD | -182.707% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -20450.665% |
| Vaxcyte, Inc. | -464.88 Million USD | -21.636% |
| PDS Biotechnology Corporation | -40.08 Million USD | -1310.673% |
| Precigen, Inc. | -89.22 Million USD | -533.748% |
| Pharming Group N.V. | 9.87 Million USD | 5825.099% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -255.531% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -2384.263% |
| PureTech Health plc | -11.62 Million USD | -4763.404% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -3230.004% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -142.174% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -2245.182% |
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -546.789% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -1852.381% |
| Acelyrin, Inc. | -381.52 Million USD | -48.212% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -4388513.329% |
| Summit Therapeutics Inc. | 1 Million USD | 56590.31% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -1593.728% |
| Senti Biosciences, Inc. | -61.33 Million USD | -821.919% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -403.515% |
| Elevation Oncology, Inc. | -41.46 Million USD | -1263.658% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -1729.757% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -9144.891% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -176058.255% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -1642.421% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -6634.969% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -861.844% |
| Seer, Inc. | -97.88 Million USD | -477.686% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -809.156% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -765.093% |
| ESSA Pharma Inc. | -26.45 Million USD | -2037.446% |
| GlycoMimetics, Inc. | -39.12 Million USD | -1345.397% |
| GT Biopharma, Inc. | 5.97 Million USD | 9557.568% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -173.579% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -8133.372% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 751.371% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -896.349% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -1004.02% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -5619.363% |
| Sorrento Therapeutics, Inc. | -539.92 Million USD | -4.73% |
| TRACON Pharmaceuticals, Inc. | -6.88 Million USD | -8114.236% |
| Viracta Therapeutics, Inc. | -46.86 Million USD | -1106.666% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -138.975% |
| Aptose Biosciences Inc. | -52.26 Million USD | -981.863% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -424.829% |
| Soligenix, Inc. | -7.85 Million USD | -7100.8% |
| Century Therapeutics, Inc. | -121.2 Million USD | -366.527% |
| Kura Oncology, Inc. | -164.95 Million USD | -242.801% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -605.97% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -5506.464% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -58941.973% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -13022.952% |
| Autolus Therapeutics plc | -156.77 Million USD | -260.699% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -567.952% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -719.507% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -2736.701% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -198.758% |
| GRI Bio, Inc. | -10.89 Million USD | -5088.732% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -12422.225% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -361.584% |
| IGM Biosciences, Inc. | -253.35 Million USD | -123.189% |
| INmune Bio, Inc. | - USD | Infinity% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -444.809% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1382.875% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -3588.418% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -3491.814% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -894.754% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -427.967% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -112.584% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -191.57% |
| Verastem, Inc. | -83.16 Million USD | -579.927% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -1018.144% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -257.375% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -395.638% |
| Histogen Inc. | -10.5 Million USD | -5283.871% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -3859.941% |
| Surrozen, Inc. | -41.13 Million USD | -1274.798% |
| Organovo Holdings, Inc. | -14.8 Million USD | -3719.181% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 17632404.334% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -863.102% |
| Panbela Therapeutics, Inc. | -51.29 Million USD | -1002.406% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -2525.322% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -6681.814% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -240.508% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -1047.961% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -2239.932% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -3656.005% |
| Apollomics, Inc. | -171.74 Million USD | -229.245% |
| Amarin Corporation plc | -50.9 Million USD | -1010.906% |
| Mesoblast Limited | -61.33 Million USD | -821.994% |
| Turnstone Biologics Corp. | -56.23 Million USD | -905.562% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -294.877% |
| Synaptogenix, Inc. | -8.3 Million USD | -6706.711% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -3586.472% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -796.899% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -11701.566% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 131898.741% |
| Exelixis, Inc. | 196.6 Million USD | 387.621% |
| Better Therapeutics, Inc. | -38.26 Million USD | -1377.884% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -299.881% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | -14.187% |
| NLS Pharmaceutics AG | -11.79 Million USD | -4693.867% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 228834.386% |
| Aridis Pharmaceuticals, Inc. | -29.5 Million USD | -1816.451% |
| Gritstone bio, Inc. | -126.86 Million USD | -345.731% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -770.152% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -14036.891% |
| Avid Bioservices, Inc. | -11.48 Million USD | -4825.25% |
| Insmed Incorporated | -654.73 Million USD | 13.635% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -25035.05% |
| MediWound Ltd. | -4.89 Million USD | -11456.673% |
| OmniAb, Inc. | -49.73 Million USD | -1037.053% |
| Alector, Inc. | -142.89 Million USD | -295.731% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -561.877% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -984.352% |
| Zai Lab Limited | -366.57 Million USD | -54.258% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -94.562% |
| Aura Biosciences, Inc. | -83.69 Million USD | -575.621% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -151.041% |
| Immunic, Inc. | -99.11 Million USD | -470.534% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -329.458% |
| Veracyte, Inc. | -49.4 Million USD | -1044.464% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -7905.005% |
| FibroGen, Inc. | -261.4 Million USD | -116.319% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -4975.559% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -7976.582% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -2921.168% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 139.013% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -2124.325% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 1517.568% |
| TG Therapeutics, Inc. | 26.1 Million USD | 2266.544% |
| Galecto, Inc. | -37.51 Million USD | -1407.151% |
| Calithera Biosciences, Inc. | -38.26 Million USD | -1377.768% |
| Fortrea Holdings Inc. | 167.3 Million USD | 437.996% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -321.111% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -1897.344% |
| XBiotech Inc. | -35.76 Million USD | -1481.021% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -770.152% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -766.618% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -441.351% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -2102.664% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -1283.679% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | -9.49% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -909.386% |
| Vaxxinity, Inc. | -56.05 Thousand USD | -1008745.516% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -386.069% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -2450.651% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -140.559% |
| NexImmune, Inc. | -28.16 Million USD | -1907.519% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -10133.7% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -4695.242% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 112.15% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -2126.953% |
| Scopus BioPharma Inc. | -11.71 Million USD | -4727.634% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -349.333% |
| Ainos, Inc. | -8.77 Million USD | -6345.477% |
| Pluri Inc. | -20.22 Million USD | -2695.886% |
| Prothena Corporation plc | -190.1 Million USD | -197.446% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -341.09% |
| Celularity Inc. | -183.94 Million USD | -207.41% |
| Rallybio Corporation | -72.37 Million USD | -681.325% |
| Cue Biopharma, Inc. | -46.05 Million USD | -1127.89% |
| MeiraGTx Holdings plc | -57.05 Million USD | -891.145% |
| Omeros Corporation | -163.61 Million USD | -245.619% |
| Humacyte, Inc. | -96.45 Million USD | -486.232% |
| Immunocore Holdings plc | -59.64 Million USD | -847.992% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -2818.996% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -2220.821% |
| Blueprint Medicines Corporation | -474.61 Million USD | -19.143% |
| CalciMedica, Inc. | -34.18 Million USD | -1553.947% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -672.139% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -350.583% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -235.687% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -124.045% |
| Pulmatrix, Inc. | -12.64 Million USD | -4371.517% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -1615.307% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -539.185% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | -11.683% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -458.68% |
| Cytokinetics, Incorporated | -456.68 Million USD | -23.82% |
| Eloxx Pharmaceuticals, Inc. | -33.37 Million USD | -1594.388% |
| Nutriband Inc. | -5.12 Million USD | -10940.465% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -1206.776% |
| Vor Biopharma Inc. | -114.37 Million USD | -394.416% |
| Roivant Sciences Ltd. | -996.51 Million USD | 43.255% |
| Evogene Ltd. | -23.2 Million USD | -2336.942% |
| ProKidney Corp. | -147.66 Million USD | -282.929% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -776.219% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -369127.354% |
| CorMedix Inc. | -48.88 Million USD | -1056.683% |
| BioLineRx Ltd. | -57.06 Million USD | -890.989% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -405.975% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -279834.653% |
| Atai Life Sciences N.V. | -36.31 Million USD | -1457.291% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -611.129% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -595.421% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -105.249% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1739.519% |
| MediciNova, Inc. | -9.87 Million USD | -5623.378% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -348.994% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -36853.838% |
| GeoVax Labs, Inc. | -26.66 Million USD | -2020.338% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -151.329% |
| Biomea Fusion, Inc. | -124.62 Million USD | -353.754% |
| PTC Therapeutics, Inc. | -330.34 Million USD | -71.178% |
| Mereo BioPharma Group plc | -26.05 Million USD | -2070.203% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -197.085% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -145.918% |
| Absci Corporation | -95.45 Million USD | -492.38% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1783.324% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -427.893% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -142.195% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -2374.154% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -172.074% |
| Allakos Inc. | -189.91 Million USD | -197.748% |
| Imunon, Inc. | -19.87 Million USD | -2744.653% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -421.207% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 622.015% |
| BioAtla, Inc. | -122.24 Million USD | -362.585% |
| NLS Pharmaceutics AG | -11.79 Million USD | -4693.867% |
| Bio-Path Holdings, Inc. | -15.76 Million USD | -3487.767% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -88.305% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -1264.316% |
| XOMA Corporation | -39.36 Million USD | -1336.584% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -469.718% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -380.636% |
| aTyr Pharma, Inc. | -52.17 Million USD | -983.729% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -574.662% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -280.451% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -141.071% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -4041.712% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -6931.173% |
| Akari Therapeutics, Plc | -16.8 Million USD | -3265.48% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 299755.549% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 225.118% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -8751.169% |
| UroGen Pharma Ltd. | -63.83 Million USD | -785.883% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -732.611% |
| ZIVO Bioscience, Inc. | -7.26 Million USD | -7685.585% |
| Orgenesis Inc. | -60.71 Million USD | -831.302% |
| Entera Bio Ltd. | -8.8 Million USD | -6322.853% |
| GH Research PLC | -41.15 Million USD | -1274.063% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -2115.871% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -587.641% |
| Xencor, Inc. | -125.87 Million USD | -349.233% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -39538.988% |
| Replimune Group, Inc. | -230.19 Million USD | -145.644% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -2705.232% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -5067.867% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -8751.169% |
| Portage Biotech Inc. | -18.19 Million USD | -3007.138% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -36853.838% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -440.683% |
| OncoCyte Corporation | -23.12 Million USD | -2345.479% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -4903.981% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -4835.637% |
| Purple Biotech Ltd. | -22.22 Million USD | -2444.288% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -8721.654% |
| scPharmaceuticals Inc. | -46.06 Million USD | -1127.65% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -3075.059% |
| HilleVax, Inc. | -132.46 Million USD | -326.878% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -5218.048% |
| Tharimmune, Inc. | -9.3 Million USD | -5978.609% |
| Genprex, Inc. | -31.06 Million USD | -1720.533% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -201.541% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -1703.496% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -73914.136% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 374820.352% |
| OKYO Pharma Limited | -15.74 Thousand USD | -3591114.712% |
| Savara Inc. | -59.13 Million USD | -856.265% |
| Curis, Inc. | -45.13 Million USD | -1152.726% |
| Daré Bioscience, Inc. | -30.7 Million USD | -1741.824% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -3622.352% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -7792.087% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -2015.164% |
| BeiGene, Ltd. | -1.12 Billion USD | 49.719% |
| Kiromic BioPharma, Inc. | -16.3 Million USD | -3368.873% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | -31.326% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -525.933% |
| Erasca, Inc. | -121.31 Million USD | -366.135% |
| bluebird bio, Inc. | -167.16 Million USD | -238.277% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -12469.43% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 282.242% |
| DBV Technologies S.A. | -85.98 Million USD | -557.659% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -12469.43% |
| Moderna, Inc. | -3.28 Billion USD | 82.776% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -1227.109% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -9911.827% |
| Molecular Templates, Inc. | 1.43 Million USD | 39643.217% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -844.777% |
| Travere Therapeutics, Inc. | -326.24 Million USD | -73.326% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -312.482% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -1093.827% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -306.712% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -174.686% |
| MacroGenics, Inc. | 2.01 Million USD | 28135.102% |
| RenovoRx, Inc. | -11.39 Million USD | -4864.601% |
| Adicet Bio, Inc. | -136.53 Million USD | -314.156% |
| Prime Medicine, Inc. | -193.75 Million USD | -191.841% |
| Aditxt, Inc. | -25.45 Million USD | -2121.183% |
| Adagene Inc. | -14.95 Million USD | -3682.196% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7635.437% |
| Quantum-Si incorporated | -91.8 Million USD | -515.951% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 179.374% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 547.169% |
| SciSparc Ltd. | -5.28 Million USD | -10605.566% |
| Vericel Corporation | 2.86 Million USD | 19843.994% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -593829.082% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -2506.873% |
| Generation Bio Co. | -133.3 Million USD | -324.207% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -581.041% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -557.345% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -148.629% |
| Invivyd, Inc. | -196.61 Million USD | -187.602% |
| Relay Therapeutics, Inc. | -374.15 Million USD | -51.133% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -5996.823% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 2182.448% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -5397.987% |
| 2seventy bio, Inc. | -206.41 Million USD | -173.943% |
| ADMA Biologics, Inc. | 5.12 Million USD | 11144.297% |
| Clene Inc. | -43.24 Million USD | -1207.713% |
| Capricor Therapeutics, Inc. | -23 Million USD | -2357.597% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -1066.467% |
| GeoVax Labs, Inc. | -26.66 Million USD | -2020.338% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -88.762% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -1439.554% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 2498.795% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 11616.062% |
| Finch Therapeutics Group, Inc. | -32.48 Million USD | -1640.866% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -256.978% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 17.366% |
| Evaxion Biotech A/S | -21.4 Million USD | -2542.003% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -751.416% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -159.783% |
| Trevena, Inc. | -35.28 Million USD | -1502.437% |
| Surrozen, Inc. | -41.13 Million USD | -1274.798% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -610.458% |
| Cingulate Inc. | -22.95 Million USD | -2363.695% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -7478.984% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -1416.691% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -6773.845% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -452.938% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -733.692% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -868.732% |
| Clearmind Medicine Inc. | -8.71 Million USD | -6391.676% |
| Kronos Bio, Inc. | -121.83 Million USD | -364.145% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -660.631% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -23061.496% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -460.83% |
| Statera Biopharma, Inc. | 38.93 Million USD | 1552.34% |
| ImmunityBio, Inc. | -436.18 Million USD | -29.64% |
| Korro Bio, Inc. | -80.9 Million USD | -598.937% |
| Kineta, Inc. | -15.71 Million USD | -3498.498% |
| BioVie Inc. | -31.95 Million USD | -1669.841% |
| Codexis, Inc. | -49.28 Million USD | -1047.39% |
| Celularity Inc. | -183.94 Million USD | -207.41% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -155.279% |
| Celcuity Inc. | -58.3 Million USD | -869.762% |
| Virax Biolabs Group Limited | -6.6 Million USD | -8455.843% |
| Cibus, Inc. | -314.58 Million USD | -79.75% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| eFFECTOR Therapeutics, Inc. | -33.73 Million USD | -1576.305% |
| IN8bio, Inc. | -28.5 Million USD | -1883.82% |
| Kodiak Sciences Inc. | -259.02 Million USD | -118.308% |
| Annexon, Inc. | -141.57 Million USD | -299.412% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -402.196% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -780.846% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -1922.779% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -145.845% |
| Eyenovia, Inc. | -24.1 Million USD | -2245.753% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 1362.656% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -174427.16% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -666.175% |
| Arcellx, Inc. | -64.14 Million USD | -781.546% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -1156.205% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -357.958% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -1731.06% |
| Moolec Science SA | -52.07 Million USD | -985.861% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -995.741% |
| Geron Corporation | -174.78 Million USD | -223.528% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -1299.085% |
| Royalty Pharma plc | 1.88 Billion USD | 129.962% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -372.827% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -5964.485% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -2626.362% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -240.479% |
| Humacyte, Inc. | -96.45 Million USD | -486.232% |
| Structure Therapeutics Inc. | -102.45 Million USD | -451.897% |
| 89bio, Inc. | -134.46 Million USD | -320.538% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -616.917% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 14055.281% |
| Genelux Corporation | -24.16 Million USD | -2240.029% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -1572.982% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -245.928% |
| Notable Labs, Ltd. | -14.4 Million USD | -3826.861% |
| Liquidia Corporation | -70.05 Million USD | -707.223% |
| Mustang Bio, Inc. | -48.06 Million USD | -1076.514% |
| Immunovant, Inc. | -269.97 Million USD | -109.45% |
| Quantum-Si incorporated | -91.8 Million USD | -515.951% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -696.591% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -2828.672% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -454.315% |
| Acasti Pharma Inc. | -11.3 Million USD | -4903.699% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -2441.059% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -3588.418% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -168.614% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -13141.747% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -3460.882% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -1865.068% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -1427.054% |
| PepGen Inc. | -83.58 Million USD | -576.543% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -1816.581% |
| United Therapeutics Corporation | 1.38 Billion USD | 140.775% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -2369.616% |
| Solid Biosciences Inc. | -93.43 Million USD | -505.206% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -11750.362% |
| Immuneering Corporation | -58.06 Million USD | -873.924% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 17632404.334% |
| Silo Pharma, Inc. | -3.62 Million USD | -15493.895% |
| Belite Bio, Inc | -31.52 Million USD | -1693.485% |
| XOMA Corporation | -39.36 Million USD | -1336.584% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -738.389% |
| Bionomics Limited | -9.83 Million USD | -5648.381% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -573.296% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1534.017% |
| uniQure N.V. | -253.1 Million USD | -123.417% |
| Cassava Sciences, Inc. | -95.68 Million USD | -490.956% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -7635.437% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -336.641% |
| Forte Biosciences, Inc. | -32.47 Million USD | -1641.134% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -6924.034% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -1903.856% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -174427.16% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -4975.559% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -3456.179% |
| Altimmune, Inc. | -87.93 Million USD | -543.052% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -514.112% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -1534.017% |
| Compugen Ltd. | -12.51 Million USD | -4417.961% |
| Peak Bio, Inc. | -1356.23 USD | -41694007.932% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -1063.562% |
| Benitec Biopharma Inc. | -22.49 Million USD | -2414.309% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -133.372% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -1881.109% |
| Zura Bio Limited | -60.56 Million USD | -833.686% |
| PolyPid Ltd. | -20.26 Million USD | -2690.643% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -3521.777% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -1881.109% |
| Instil Bio, Inc. | -146.12 Million USD | -286.983% |
| argenx SE | -216.02 Million USD | -161.763% |
| Immunome, Inc. | -28.27 Million USD | -1900.17% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -1066.563% |
| Verona Pharma plc | -52.46 Million USD | -977.747% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -496.661% |
| Shattuck Labs, Inc. | -87.61 Million USD | -545.401% |
| CervoMed Inc. | -2.17 Million USD | -25935.949% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -362.573% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -4354.959% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -1073.803% |
| Moolec Science SA | -52.07 Million USD | -985.861% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -3199.116% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -333.671% |
| AnaptysBio, Inc. | -143.16 Million USD | -294.979% |
| Design Therapeutics, Inc. | -66.32 Million USD | -752.571% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -598.221% |
| NeurAxis, Inc. | -6.66 Million USD | -8384.784% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -1397.928% |
| Lumos Pharma, Inc. | -36.57 Million USD | -1446.262% |
| Achilles Therapeutics plc | -70.44 Million USD | -702.743% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -496.661% |
| 180 Life Sciences Corp. | -22.13 Million USD | -2454.745% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 9800.533% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -23061.496% |
| Nutriband Inc. | -5.12 Million USD | -10940.465% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -415.242% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -920.111% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -1018.631% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -766.259% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -945.035% |
| Palisade Bio, Inc. | -12.28 Million USD | -4504.413% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -1146.183% |
| Beam Therapeutics Inc. | -156.47 Million USD | -261.384% |
| Neurogene Inc. | -52.28 Million USD | -981.49% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -314.293% |
| AEON Biopharma, Inc. | -48.36 Million USD | -1069.264% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -507.912% |
| Sesen Bio, Inc. | -50.84 Million USD | -1012.25% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -590.167% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -4478.68% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | -32.294% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -437.532% |
| Athira Pharma, Inc. | -116.7 Million USD | -384.536% |
| Vaccinex, Inc. | -19.74 Million USD | -2763.419% |
| HCW Biologics Inc. | -23.57 Million USD | -2298.484% |
| XOMA Corporation | -39.36 Million USD | -1336.584% |
| Nektar Therapeutics | -243.1 Million USD | -132.6% |
| Arvinas, Inc. | -394.8 Million USD | -43.229% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 299755.549% |
| Merus N.V. | -149.2 Million USD | -278.982% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -504.843% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -1708.919% |
| Rezolute, Inc. | -68.42 Million USD | -726.43% |
| Clene Inc. | -43.24 Million USD | -1207.713% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -3566.587% |
| BeyondSpring Inc. | -21.54 Million USD | -2525.2% |
| Synlogic, Inc. | -55.16 Million USD | -925.123% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -4579.864% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -5213.55% |
| Peak Bio, Inc. | -1356.23 USD | -41694007.932% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -1641.777% |
| Krystal Biotech, Inc. | 17.9 Million USD | 3258.333% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -377.498% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | -65.658% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -12175.618% |
| MannKind Corporation | 15.12 Million USD | 3837.643% |
| Ikena Oncology, Inc. | -74.39 Million USD | -660.068% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -4390.336% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 2881.857% |
| Gossamer Bio, Inc. | -172.15 Million USD | -228.47% |
| CohBar, Inc. | -12.06 Million USD | -4586.551% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -2116.739% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1783.324% |
| Legend Biotech Corporation | -477.87 Million USD | -18.33% |
| Mural Oncology plc | -192.72 Million USD | -193.414% |
| Biora Therapeutics, Inc. | -114.05 Million USD | -395.79% |
| PaxMedica, Inc. Common Stock | -16.14 Million USD | -3402.376% |
| Disc Medicine, Inc. | -91.02 Million USD | -521.223% |
| Champions Oncology, Inc. | -5.05 Million USD | -11088.524% |
| REGENXBIO Inc. | -239.46 Million USD | -136.139% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -5175.78% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -914.183% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -1358.585% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -401.275% |
| Vaxart, Inc. | -74.72 Million USD | -656.752% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -1506.065% |
| Cellectis S.A. | -98.09 Million USD | -476.449% |
| Longeveron Inc. | -20.06 Million USD | -2718.883% |
| Repare Therapeutics Inc. | -114.27 Million USD | -394.84% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | -28.751% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -655.852% |
| Revolution Medicines, Inc. | -430.58 Million USD | -31.326% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -8891.382% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -1736.591% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -658.102% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 11633.102% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -5057.027% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 112.279% |
| Denali Therapeutics Inc. | -179.97 Million USD | -214.196% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -593829.082% |
| Veru Inc. | -89.97 Million USD | -528.468% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -2003.832% |
| Cingulate Inc. | -22.95 Million USD | -2363.695% |
| Passage Bio, Inc. | -98.34 Million USD | -475.007% |
| Context Therapeutics Inc. | -25.06 Million USD | -2156.405% |
| Exicure, Inc. | -15.53 Million USD | -3539.024% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -174.414% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -1429.284% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -9383.587% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -235.661% |
| Nuvalent, Inc. | -149.49 Million USD | -278.26% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -6853.261% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -558.332% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -1773.776% |
| OmniAb, Inc. | -49.73 Million USD | -1037.053% |
| Anew Medical, Inc. | -1.3 Million USD | -43369.451% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -4473.504% |
| Lipocine Inc. | -16.32 Million USD | -3364.312% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -748.16% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -661.03% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -1382.875% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -1349.398% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -2449.105% |
| Sage Therapeutics, Inc. | -545.07 Million USD | -3.742% |
| Ocugen, Inc. | -64.82 Million USD | -772.272% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -510.854% |
| Q32 Bio Inc. | -86.5 Million USD | -553.705% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -3240.627% |
| Alumis Inc. Common Stock | -156.89 Million USD | -260.423% |
| Equillium, Inc. | -12.13 Million USD | -4558.659% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -867.075% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -7054.79% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -2898.085% |
| Galera Therapeutics, Inc. | -46.69 Million USD | -1111.06% |
| Evelo Biosciences, Inc. | -106.34 Million USD | -431.73% |
| Comera Life Sciences Holdings, Inc. | -17.88 Million USD | -3061.408% |
| Dominari Holdings Inc. | -22.44 Million USD | -2419.911% |
| Edesa Biotech, Inc. | -8.19 Million USD | -6804.251% |
| vTv Therapeutics Inc. | -25.41 Million USD | -2125.201% |
| Bio-Techne Corporation | 326.66 Million USD | 273.104% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | -46.927% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 361.32% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -331.299% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -1410.694% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -274.232% |
| Nkarta, Inc. | -120.48 Million USD | -369.342% |
| BioCardia, Inc. | -11.56 Million USD | -4791.592% |
| Iterum Therapeutics plc | -34.58 Million USD | -1535.246% |